Sex-Based Outcomes of Dual-Antiplatelet Therapy After Percutaneous Coronary Intervention: A Pairwise and Network Meta-Analysis

Thomas A. Agbaedeng,Jean Jacques Noubiap,Kirsty A. Roberts,Derek P. Chew,Peter J. Psaltis,Azmeraw T. Amare
DOI: https://doi.org/10.1007/s40265-024-02034-3
2024-05-30
Drugs
Abstract:Although dual antiplatelet therapy (DAPT) improves the outcomes of patients undergoing percutaneous coronary intervention (PCI), sex-specific differences in efficacy and safety of DAPT remain unresolved. We compared sex differences for DAPT outcomes and DAPT durations (1–3 months [short-term], 6 months [mid-term], and >12 months [extended] vs. 12 months).
pharmacology & pharmacy,toxicology
What problem does this paper attempt to address?